SCHEMBL4096718

SCHEMBL4096718

CC(CCc1cn[nH]c1)n1cc(-c2ccnc3c2ccn3COCC[Si](C)(C)C)cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15970035 0.89 CHUK (0.34)
SCHEMBL99248 0.86 JAK2 (0.35)
SCHEMBL101161 0.86 GRM4 (0.34)
SCHEMBL101210 0.86 JAK2 (0.33)
SCHEMBL2148207 0.82 DGAT1 (0.30)
SCHEMBL100496 0.82 LMNA (0.32)
SCHEMBL15970036 0.82 CHUK (0.31)
SCHEMBL98937 0.81 AURKA (0.41)
SCHEMBL30636557 0.81 AURKA (0.41)
SCHEMBL12262943 0.80 JAK2 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415362-B2 Pyrazolyl substituted pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors INCYTE CORPORATION (US) 2013-04-09 US disclosed
US-20090181959-A1 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS INCYTE CORPORATION (US) 2009-07-16 US disclosed